from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3266c/rmlD

LFCtreatmentdescriptionclass of inhibitor

-0.214

Amikacinug/mL Amikacintranslation

-0.249

Cap5-10ug/mL Capreomycintranslation

-0.125

Rox10-50 ug/mL Roxithromycintranslation

1.488

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.467

Rif0.2-5ug/mL Rifampicintranscription

-0.153

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.615

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.474

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.061

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.107

Clofazimine10-13 ug/mL Clofaziminerespiration

0.362

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.269

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.333

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.059

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.503

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.190

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.075

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.147

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.742

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.150

KCN5-20 ug/mL Potassium cyaniderespiration

-0.752

NaN30.2-2 mM Sodium aziderespiration

-0.519

Nigericin50 uM Nigericinrespiration

0.389

TRC10-150 ug/mL Triclosanrespiration

-0.279

TRZ10-25 ug/mL Thioridazinerespiration

-1.049

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.236

menadione6-10 ug/mL Menadionerespiration

-0.476

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.889

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.676

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.006

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.329

NRP_1Non-replicating persistence stage 1dosRassociated

-0.163

Amp0.2mg/mL AmpicillincellWall

-0.273

Cephalexin20-100 ug/mL CephalexincellWall

-0.107

Cerulenin0.32-5 ug/mL CerulenincellWall

0.080

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.251

EMB10-20 ug/mL EthambutolcellWall

0.160

Eta12-40 ug/mL EthionamidecellWall

0.154

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.023

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.014

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.253

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.474

BZA0.12 mg/mL BenzamidearomaticAmides

0.027

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.001

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.150

H2O24 mM hydrogen peroxideDNAdamaging

-0.274

Levo10 ug/mL LevofloxacinDNAdamaging

0.117

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.727

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.013

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.167

UVUV-irradiationDNAdamaging

-0.838

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.557

Antimycin12.5-50 ug/mL Antimycin A?

-0.546

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.353

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.486

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.499

PA8240.2-2 ug/mL PA-824?

0.825

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.061

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.742

Verapamil50 uM Verapamil?

1.456

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.087

methoxatin10-20 ug/mL Methoxatin?